Abstract:Background and Objective: MicroRNA dysregulation is a pivotal pathogenic mechanism in the development of various neurodegenerative conditions, including diabetic retinal neurodegeneration. MicroRNA-183 (miR-183) exerts a pathogenic role in diabetic retinopathy (DR). This investigation explored the pathogenic influence of miR-183 on inflammatory, apoptotic and mitochondrial signaling processes in DR. Materials and Methods: As 40 male C57BL/6 mice were split into four groups (control, DR, Ant-183 and ant-NC). The DR was induced by streptozotocin. In this study, microarray and RT qPCR, enzyme-linked immunosorbent western blot, mitochondrial membrane potential (MMP) detection and ATP assays were carried out. Results: As a result, DR mice showed substantial upregulation of miR-183, aberrant inflammation (manifested by increased TNF-α and IL-1β), apoptosis and altered retinal mitochondrial fission/fusion proteins. Furthermore, p38-Mitogen-Activated Protein Kinase (p38-MAPK)/Nuclear Factor-Kappa B (NF-κB) signaling is activated in the DR cohort. Nevertheless, inhibition of miR-183 ameliorated these pathological changes in the DR. Conclusion: The therapeutic strategies targeting the inhibition of miR-183 might halt the onset and progression of DR.

MicroRNA-183 Repression Ameliorates Mitochondrial Dysregulation and Retinal Degeneration in Mice via P38-MAPK/NF-κB Signaling: Implications for Diabetic Retinopathy